Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Rowley

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Cancer Research|April 12, 2013
FGFR1 is essential for prostate cancer progression and metastasisFeng Yang, Yongyou Zhang, Steven J Ressler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancerGustavo Ayala, Jennifer A Tuxhorn, Thomas M Wheeler, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiationWoosook Kim, David A Barron, Rebeca San Martin, et al.
The Prostate|August 12, 2004
Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survivalStephanie J McAlhany, Gustavo E Ayala, Anna Frolov, et al.
American Journal of Clinical and Experimental Urology|November 7, 2014
TGF-β induction of FGF-2 expression in stromal cells requires integrated smad3 and MAPK pathwaysDouglas W Strand, Yao-Yun Liang, Feng Yang, et al.
Oncotarget|October 22, 2014
Stromal TGF-β signaling induces AR activation in prostate cancerFeng Yang, Yizhen Chen, Tao Shen, et al.
Plos One|November 10, 2010
TGF-β1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouseDavid A Barron, Douglas W Strand, Steven J Ressler, et al.
Cancer Research|September 17, 2017
Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone MicroenvironmentRebeca San Martin, Ravi Pathak, Antrix Jain, et al.
Oncotarget|June 8, 2017
Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERGJustin M Roberts, Rebeca San Martin, D Badrajee Piyarathna, et al.
The American Journal of Pathology|September 16, 2014
WFDC1 is a key modulator of inflammatory and wound repair responsesSteven J Ressler, Truong D Dang, Samuel M Wu, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Cancer Research|April 12, 2013
FGFR1 is essential for prostate cancer progression and metastasisFeng Yang, Yongyou Zhang, Steven J Ressler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancerGustavo Ayala, Jennifer A Tuxhorn, Thomas M Wheeler, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiationWoosook Kim, David A Barron, Rebeca San Martin, et al.
The Prostate|August 12, 2004
Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survivalStephanie J McAlhany, Gustavo E Ayala, Anna Frolov, et al.
American Journal of Clinical and Experimental Urology|November 7, 2014
TGF-β induction of FGF-2 expression in stromal cells requires integrated smad3 and MAPK pathwaysDouglas W Strand, Yao-Yun Liang, Feng Yang, et al.
Oncotarget|October 22, 2014
Stromal TGF-β signaling induces AR activation in prostate cancerFeng Yang, Yizhen Chen, Tao Shen, et al.
Plos One|November 10, 2010
TGF-β1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouseDavid A Barron, Douglas W Strand, Steven J Ressler, et al.
Cancer Research|September 17, 2017
Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone MicroenvironmentRebeca San Martin, Ravi Pathak, Antrix Jain, et al.
Oncotarget|June 8, 2017
Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERGJustin M Roberts, Rebeca San Martin, D Badrajee Piyarathna, et al.
The American Journal of Pathology|September 16, 2014
WFDC1 is a key modulator of inflammatory and wound repair responsesSteven J Ressler, Truong D Dang, Samuel M Wu, et al.
Pageof 5